G. Archer

发表

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.

A. Friedman, D. Bigner, G. Dranoff, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Treatment of neoplastic meningitis with intrathecal temozolomide.

W. R. Bishop, R. McLendon, A. Friedman, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide

D. Bigner, A. Heimberger, J. Sampson, 2013, Cancer Immunology, Immunotherapy.

Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.

R. McLendon, D. Bigner, P. Garg, 1994, Cancer research.

Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.

D. Bigner, H. Friedman, M. Zalutsky, 1990, Cancer research.

Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis.

R. McLendon, I. Pastan, D. Bigner, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.

P. Humphrey, D. Bigner, H. Friedman, 1991, Biochemical and biophysical research communications.

Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.

R. McLendon, D. Bigner, H. Friedman, 1993, Cancer research.

Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells

Ryan M. Schweller, R. McLendon, J. West, 2018, Journal of Clinical Neuroscience.

Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.

D. Bigner, P. Garg, M. Zalutsky, 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

Isolation and Generation of Human Dendritic Cells

S. Nair, T. Tedder, G. Archer, 1997, Current protocols in immunology.

Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.

R. McLendon, A. Friedman, I. Pastan, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis.

R. McLendon, D. Bigner, M. Zalutsky, 1999, International journal of radiation oncology, biology, physics.

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.

D. Bigner, G. Dranoff, J. Sampson, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.

R. McLendon, A. Friedman, D. Bigner, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parent.

D. Bigner, S. Batra, P. Garg, 1996, Nuclear medicine and biology.

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

D. Bigner, M. Zalutsky, G. Archer, 1998, Journal of neurovirology.

Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy

J. Herndon, J. Sampson, Anirudh Saraswathula, 2016, Cancer Immunology, Immunotherapy.

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

P. Humphrey, B. Vogelstein, D. Bigner, 1990, Proceedings of the National Academy of Sciences of the United States of America.

PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment.

P. Garg, M. Zalutsky, R. Page, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea

R. McLendon, D. Bigner, S. Kurpad, 1997, Cancer Chemotherapy and Pharmacology.

Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.

R. McLendon, D. Bigner, S. Kurpad, 1995, Cancer research.

Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.

R. McLendon, I. Pastan, D. Bigner, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion.

D. Bigner, G. Dranoff, J. Sampson, 1997, Neurosurgery.

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

M. Willingham, D. Bigner, S. Kurpad, 1995, Cancer research.

Continuous human glioma-derived cell lines UC-11MG and UC-302MG

G. Archer, B. Liwnicz, S. Soukup, 2004, Journal of Neuro-Oncology.

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

Mitchel S Berger, Allan H Friedman, James M Provenzale, 2008, Neuro-oncology.

Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas

P. Humphrey, D. Bigner, M. Shibuya, 1993, Journal of Neuroimmunology.

Effect of daclizumab on TReg counts and EGFRvIII-specific immune responses in GBM.

D. Bigner, H. Friedman, D. Reardon, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL

E. Thompson, E. Lipp, M. Khasraw, 2021, Neuro-Oncology.

Immunocytochemical Binding to Neurons of Serum from Spinocerebellar Degeneration Patients

S. Dhib-jalbut, G. Archer, B. Liwnicz, 1986, Journal of child neurology.

Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.

D. Bigner, M. Zalutsky, C. Reist, 1997, Cancer research.

Radiotoxicity of systematically administered [211At]astatide in B6C3F1 and BALB/c (nu/nu) mice: a long-term survival study with histologic analysis.

R. McLendon, D. Bigner, P. Garg, 1996, International journal of radiation oncology, biology, physics.

Local production of TGF beta1 inhibits cerebral edema, enhances TNF-alpha induced apoptosis and improves survival in a murine glioma model.

D. Bigner, J. Sampson, D. Ashley, 1998, Journal of neuroimmunology.

Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.

J. Herndon, E. Lipp, H. Friedman, 2019, Journal of Clinical Oncology.

Epidermal growth factor receptor variant III (EGFRvIII) vaccine (CDX-110) in GBM.

D. Bigner, H. Friedman, D. Reardon, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.